Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
Clinical trial NCT01953926 · TERMINATED
Trial details
- NCT number
- NCT01953926
- Sponsor
- Puma Biotechnology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-30
- Primary completion
- 2023-01-02
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.